参 考 文 献
[1]
刘文忠，谢勇，陆红，等．
第五次全国幽门螺杆菌感染处理共识报告[J]．
中华消华志，
2017，
37(
6)：
364-
378.
.
LiuWZ, XieY, LuH，et al.Interpretation of the fifth Chinese national consensus report on management of helicobacter pylori infection[J]．Chin J Gig，2017，37(6)：364-378..
[2]
中华医学会消化病分会．
中国慢性胃炎共识意见(2017，上海)[J]．
胃肠病学，
2017，
22(
11)：
670-
687.
.
Chinese Society of Gastroenterology.Consensus opinion on chronic gastritis in China(2017，Shanghai)[J]．Chin J Gastroenterol，2017，22(11)：670-687..
[3]
蒋朱明，詹思延，贾晓巍，等．
制定/修订《临床诊疗指南》的基本方法及程序[J]．
中华消化杂志，
2016，
96(
4)：
250-
253.
.
JiangZM, ZhanSY, JiaXW，et al.Basic methods and procedures for formulating / revising the clinical diagnosis and treatment guidelines[J]．Chin J Gig，2016，96(4)：250-253..
[4]
QaseemA, SnowV, OwensDK，et al.
The development of clinical practice guidelines and guidance statements of the American College of Physicians：summary of methods[J]．
Ann Intern Med，
2010，
153(
3)：
194.
.
[5]
SipponenP, MaaroonsHI.
Chronic gastritis[J]．
Scand J Gastroenterol，
2015，
50(
6)：
657-
667.
.
[6]
PilottoA, SallesN．
Helicobacter pylori infection in geriatrics[J]．
Helicobacter，
2002，
7(
s1)：
56-
62.
.
[7]
MarquessilvaL, AreiaM, ElvasL，et al.
Prevalence of gastric precancerous conditions：a systematic review and meta-analysis[J]．
Eur J Gastroenterol Hepatol，
2014，
26(
4)：
378-
387.
.
[8]
陈敏敏，郑松柏，肖立，等．
胃窦幽门腺组织学和超微结构的增龄变化研究[J]．
中华老年医学杂志，
2014，
33(
8)：
887-
890.
.
ChenMM, ZhengSB, XiaoL，et al.Age-associated changes in the histology and ultrastructure of pyloric glands[J]．Chin J Geriatr，2014，33(8)：887-890..
[9]
庄艳，郑松柏，李小雯，等．
人体和比格犬胃底黏膜组织学形态及其主细胞超微结构的增龄变化[J]．
中华消化杂志，
2016，
36(
9)：
597-
601.
.
ZhuangY, ZhengSB, LiXW.Age-associated histological changes of gastric fundal mucosa and ultrastructure of gastric chief cells in human and Beagle dogs[J]．Chin J Gig，2016，36(9)：597-601..
[10]
DuY, BaiY, XieP，et al.
Chronic gastritis in China.a national multi-center survey[J]．
BMC Gastroenterol，
2014，
14(
1)：
21.
.
[11]
KinoshitaY, ChibaT．
Characteristics of Japanese patients with chronic gastritis and comparison with functional dyspepsia defined by ROME Ⅲ criteria：based on the large-scale survey，FUTURE study[J]．
Inter Med，
2011，
50(
20)：
2269-
2276.
.
[12]
RedeenS, PeterssonF, JonssonKA，et al.
Relationship of gastroscopic features to histological findings in gastritis and Helicobacter pylori infection in a general population sample[J]．
Endoscopy，
2003，
35(
11)：
946-
950.
.
[13]
EshmuratovA, NahJC, KimN，et al.
The correlation of endoscopic and histological diagnosis of gastric atrophy[J]．
Dig Dis Sci，
2010，
55(
5)：
1364-
1375.
.
[14]
NomuraS, IdaK, TeraoS，et al.
Endoscopic diagnosis of gastric mucosal atrophy：multicenter prospective study[J]．
Dig Endosc，
2014，
26(
6)：
709-
719.
.
[15]
TytgatGNJ.
The Sydney System：endoscopic division.Endoscopic appearances in gastritis/Duodenitis[J]．
J Gastroenterol Hepatol，
1991，
6(
3)：
223-
234.
.
[16]
ZhaoZ, YinZ, WangS，et al.
Meta-analysis：The diagnostic efficacy of chromoendoscopy for early gastric cancer and premalignant gastric lesions[J]．
J Gastroenterol Hepatol，
2016，
31(
9)：
1539-
1545.
.
[17]
MouzykaS, FedoseevaA．
Chromoendoscopy with hematoxylin in the classification of gastric lesions[J]．
Gastric Cancer，
2008，
11(
1)：
15-
22.
.
[18]
LiZ, ZuoXL, LiCQ，et al.
New Classification of gastric pit patterns and vessel architecture using probe-based confocal laser endomicroscopy[J]．
J Gastroenterol，
2016，
50(
1)：
23-
32.
.
[19]
JiR, LiYQ, GuXM，et al.
Confocal laser endomicroscopy for diagnosis of Helicobacter pylori infection：a prospective study[J]．
J Gastroenterol Hepatol，
2010，
25(
4)：
700-
705.
.
[20]
DixonMF, GentaRM, YardleyJH，et al.
Classification and grading of gastritis.The updated sydney system.International workshop on the histopathology of gastritis，houston 1994[J]．
Am J Surg Pathol，
1996，
20(
10)：
1161-
1181.
.
[21]
中华医学会消化病学分会．
中国慢性胃炎共识意见，全国第二届慢性胃炎共识会议[J]．
胃肠病学，
2006，
11(
11)
674-
684.
.
Chinese Society of Gastroenterology.Chineses consenus on chronic，The second National Conrence on chronic gastritis[J]．Chin J Gastroenterol，2006，11(10)674-684..
[22]
HamiltonSR, AaltonenLA，
Pathology and Genetics of tumours of the Digestive system[M]．
IARC Press，
2000：
46-
52.
[23]
EctorsN, DixonMF.
The prognostic value of sulfomucin positive intestinal metaplasia in the development of gastric cancer[J]．
Histopathology，
1987，
10(
12)：
1271-
1277.
.
[24]
GonzálezCA, Sanz-AnquelaJM, GisbertJP，et al.
Utility of subtyping intestinal metaplasia as marker of gastric cancer risk.A review of the evidence[J]．
Int J Cancer，
2013，
133(
5)：
1023.
.
[25]
KimEH, KangH, ParkCH，et al.
The optimal serum pepsinogen cut-off value for predicting histologically confirmed atrophic gastritis[J]．
Dig Liver Dis，
2015，
47(
8)：
663-
668.
.
[26]
杨莉，孙明军，徐倩，等．
血清胃蛋白酶原、促胃液素-17在慢性胃窦部萎缩性胃炎诊断中的价值[J]．
中华消化杂志，
2014，
34(
7)：
478-
480.
.
YangL, SunMJ, XuQ，et al.The value of serum pepsinogen and gastrin-17 in the diagnosis of chronic atrophic gastritis of the gastric antrum[J]．Chin J Dig，2014，34(7)：478-480..
[27]
GotodaT, IshikawaH, OhnishiH，et al.
Randomized controlled trial comparing gastric cancer screening by gastrointestinal X-ray with serology for Helicobacter pylori and pepsinogens followed by gastrointestinal endoscopy[J]．
Gastri Cancer，
2015，
18(
3)：
605.
.
[28]
中华医学会消化内镜分会，中国抗癌协会肿瘤内镜学专业委员会．
中国早期胃癌筛查及内镜诊治共识意见[J]．
胃肠病学，
2014，
19(
7)：
408-
427.
.
Chinese Society of Digestive Endoscopy, Chinese Anti-Cancer Association, The Society of Oncological Endoscopy.Consensus opinion on early gastric cancer screening and endoscopic diagnosis and treatment in China[J]．Chin J Gastroenterol，2014，19(7)：408-427..
[29]
SonnenbergA, LashRH, GentaRM.
A national study of helicobactor pylori infection in gastric biopsy specimens[J]．
Gastroenterology，
2010，
139(
6)：
1894-
1901.
.
[30]
MiedererSE, WirtzM, FladungB．
Acid neutralization and bile acid binding capacity of hydrotalcite compared with other antacids：An in vitro study[J]．
Chin J Dig Dis，
2003，
4(
3)：
140-
146.
.
[31]
ChenH, LiX, GeZ，et al.
Rabeprazole combined with hydrotalcite is effective for patients with bile reflux gastritis after cholecystectomy[J]．
Can J Gastroenterol，
2010，
24(
3)：
197-
201.
.
[32]
张倩倩，郑松柏．
老年"双抗"患者的胃黏膜损害及其保护策略[J]．
胃肠病学，
2018，
23(
1)：
3-
7.
.
ZhangQQ, ZhengSB.Gastric mucosal damage induced by dual anti-platelet therapy and its prevention in elderl[J]．Chin J Gastroenterol，2018，23(1)：3-7..
[33]
中华老年医学杂志编辑委员会，中华医学会老年医学分会．
老年人质子泵抑制剂合理应用专家共识[J]．
中华老年医学杂，
2015，
34(
10)：
1045-
1052.
.
Chinese Journal of Geriatrics Editorial Board, Chinese Society of Geriatrics.Expert consensus on the rational application of proton pump inhibitors in the elderly[J]．Chin J Geriatr，2015，34(10)：1045-1052..
[34]
HiyamaT, YoshiharaM, MatsuoK，et al.
Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia[J]．
J Gastroenterol Hepatol，
2007
；22(
3)：
304-
10.
.
[35]
HoltmannG, TalleyNJ, LiebregtsT，et al.
A placebo-controlled trial of itopride in functional dyspepsia[J]．
N Engl J Med，
2006，
354(
8)：
832-
840.
.
[36]
HuangX, LyuB, ZhangS，et al.
Itopride therapy for functional dyspepsia：a meta-analysis[J]．
World J Gastroenterol，
2012，
18(
48)：
7371-
7377.
.
[37]
李小雯，郑松柏．
促胃肠动力药物安全性研究现状[J]．
中国新药与临床杂志，
2015，
34(
9)：
657-
605.
.
LiXW, ZhengSB.Current indication of safety of prokinetic agents[J]．Chin J New Drugs Clin Rem，2015.34(9)：657-605..
[38]
StanghellinV, ChanFK, HaslerWL，et al.
Gastroduodenal Disorders[J]．
Gastroenterology，
2016，
150(
6)：
1380-
1392.
.
[39]
HondeghemLM.
Domperidone：limited benefits with significant risk for sudden cardiac death[J]．
J Cardiovasc Pharmacol，
2013，
61(
3)：
218-
225.
.
[40]
中华老年医学杂志编辑委员会，中华医学会老年医学分会．
老年人功能性消化不良诊治专家共识[J]．
中华老年医学杂志，
2015，
34(
7)：
698-
705.
.
Chinese Journal of Geriatrics Editorial Board, Chinese Society Of Geriatrics.Expert consensus on the diagnosis and treatment of functional dyspepsia in the elderly[J]．Chin J Geriatr，2015，34(7)：698-705，.
[41]
BaqaiMT, MalikMN, ZiauddinF．
Efficacy and safety of cinitapride in functional dyspepsia[J]．
J Pak Med Assoc，
2013，
63(
6)：
747-
751.
[42]
RobertM, SalvaM, SegarraR，et al.
The prokinetic cinitapride has no clinically relevant phaemacokinetic interaction and effect on QT during coadministration with ketoconazole[J]．
Drug Metab Dispos，
2007，
35(
7)：
1149-
1156.
.
[43]
DuY, SuT, SongX，et al.
Efficacy and safety of cinitapride in the treatment of mild to moderate postprandial distress syndrome-predominant functional dyspepsia[J]．
J Clin Gastroenterol，
2014，
48(
4)：
328-
335.
.
[44]
ThoratV, ReddyN, BhatiaS，et al.
Randomised clinical trial：the efficacy and safety of pancreatin enteric-coated minimicrospheres(Creon 40000 MMS)in patients with pancreatic exocrine insufficiency due to chronic pancreatitis-a double-blind，placebo-controlled study[J]．
Aliment Pharmacol Ther，
2012，
36：
426-
436.
.
[45]
上海市慷彼申治疗协作组．
米曲菌胰酶片治疗消化不良症状的多中心、随机、安慰剂交叉对照临床研究[J]．
胃肠病学，
2008，
13(
12)：
713-
718.
.
Shanghai Combizym Clinical Cooperative Group.Efficacy of Oryz-Aspergillus Enzyme and Pancreatin Tablet in Patients with Dyspepsia：a Multi-center，Randomized，Placebo-controlled Cross-over Study[J]．Chin J Gastroenterol，2008，13(12)：713-718..
[46]
上海市泌特临床协作组．
复方阿嗪米特肠溶片治疗消化不良的多中心、随机、双盲、安慰剂平行对照临床研究[J]．
胃肠病学，
2005，
10(
2)：
83-
87.
.
Shanghai Mite Clinical study Cooperative Group.A multicenter，randomized，double-blind，placebo-controlled，and parallel clinical study of complex azintamide enteric tablet in the treatment of dyspepsia[J]．Chin J Gastroenterol，2005，10(2)：83-87..
[47]
上海市达吉临床研究协作组．
多种消化酶制剂治疗消化不良的多中心、随机、安慰剂、双盲、平行对照研究[J]．
胃肠病学，
2003，
8(
2)：
79-
82.
.
Shanghai Dages Clinical study Cooperative Group.A multicenter，randomized，placebo，double-blind，parallel and controlled study of multiple digestive enzymes capsule[J]．Chin J Gastroenterol，2003，8(2)：79-82..
[48]
JonesMP, OudenhoveLV, KoloskiN，et al.
Early life factors initiate a'vicious circle’of affective and gastrointestinal symptoms：A longitudinal study[J]．
United European Gastroenterol J，
2013，
1(
5)：
394-
402.
.
[49]
TalleyNJ, LockeGR, SaitoA，et al.
Effect of amitriptyline and escitalopram on functional dyspepsia：a multi-center，randomized，controlled study[J]．
Gastroenterology，
2015，
149(
2)：
340-
349.
.
[50]
BraakB, KlookerTK, WoutersMM，et al.
Randomised clinical trial：the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia，a double-blind placebo-controlled study[J]．
Aliment Pharmacol Ther，
2011，
34(
6)：
638-
648.
[51]
MaJL, ZhangL, BrownLM，et al.
Fifteen-year effects of Helicobacter pylori，garlic，And vitamin treatments on gastric cancer incidence and mortality[J]．
J Natl Cancer Inct，
2012，
104(
6)：
488-
492.
.
[52]
BrandtPA, GoldbohmRA.
Nutrition in the prevention of gastrointestinal cancer[J]．
Best Pract Res Clin Gastroenterol，
2006，
20(
3)：
589-
603.
.
[53]
FangJY, XiaoSD.
Folic acid，polymorphism of methyl-group metabolism genes，and DNA methylation in relation to GI carcinogenesis[J]．
J Gastroenterol，
2003，
38(
9)：
821-
829.
.
[54]
陆莉莉，王威，费素娟．
康复新液治疗慢性糜烂性胃炎的Meta分析[J]．
中国中西医结合消化杂志，
2015，
23(
12)：
874-
884.
.
LuLL, WangW, FeiSJ.Meta analysis of efficacyof Kangfuxin liquid in the treatment of chronic erosive gastritis[J]．Chin J Integr Trad West Med Dig，2015，23(12)，874-884..
[55]
郑波，王建嶂，裴继华，等．
胃复春联合胶体果胶铋对胃癌前病变基因的逆转性研究[J]．
中国临床药理学杂志，
2016，
32(
2)：
123-
125.
.
ZhengB, WangJZ, FeiJHet al.Gene reversal mechanism of Weifuchun combined with colloidal bismuth pectin on patients with precancerous lesion of gastric carcinoma[J]．Chin J Clin Pharmacol，2016，32(2)：123-125..
[56]
TangXD, ZhouLY, ZhangST，et al.
Randomized double-blind clinical trial of Moluodan for the treatment of chronic atrophic gastritis with dysplasia[J]．
Chin J Integr Med，
2016，
22(
1)：
1-
10.
.
[57]
YouWC, BrownLM, ZhangL，et al.
Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions[J]．
J Natl Cancer Inst，
2006，
98(
14)：
974-
983.
.
[58]
KodamaM, MurakamiK, OkimotoT，et al.
Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication[J]．
J Gastroenterol，
2012，
47(
4)：
394-
403.
.
[59]
SuganoK, TackJ, KuipersEJ，et al.
Kyoto global consensus report on Helicobacter pylori astritis[J]．
Gut，
2015，
649(
9)：
1353-
1367.
.
[60]
CorreaP．
A human model of gastric carcinogenesis[J]．
Cancer Res，
1988，
48(
13)：
3554-
3560.
[61]
CorreaP．
Human gastric carcinogenesis：a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention[J]．
Cancer Res，
1992，
52(
24)：
6735-
6740.
[62]
Korean College of Helicobacter and Upper gastrointestinal Research，
ShinWG, KimHU，et al.
Surveillance strategy of atrophic gastritis and intestinal metaplasia in a country with a high prevalence of gastric cancer[J]．
Dig Dis Sci，
2012，
57(
3)：
746-
752.
.
